IPO Calendar
Lead Manager
- J P Morgan Chase (515)
- Goldman Sachs (492)
- Morgan Stanley (445)
- Bank of America Merrill Lynch (374)
- Citigroup (236)
- Jefferies (223)
- Credit Suisse (180)
- Barclays (158)
- Cowen and Company (147)
- Deutsche Bank (85)
- Leerink Partners (73)
- Piper Jaffray (70)
- Stifel (67)
- UBS Investment Bank (56)
- Evercore (55)
- RBC Capital (53)
- BMO Capital (52)
- Wells Fargo (48)
- Piper Sandler (43)
- Revere Securities (42)
More +
IPO - Pricing (9)
Morgan Stanley
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20 | Prime Medicine, | Health Care | 17 | 10 | JPM | GS | MS | 27% | -9.6% | ||
| Sep 15 | Third Harmonic | Health Care | 17 | 10 | MS | JEFF | COWN | 19.2% | 15.8% | ||
| Sep 15 | Corebridge Fina | Finance | 21 | 80 | JPM | MS | PS | 6.2% | -2.4% | ||
| May 13 | ProFrac Holding | Energy | 18 | 16 | JPM | PS | MS | 39.5% | 0.6% | ||
| May 6 | Bausch + Lomb C | Health Care | 18 | 35 | MS | GS | CITI | 42.8% | 11.1% | ||
| Apr 13 | Excelerate Ener | Energy | 24 | 16 | BRCL | JPM | MS | 74.4% | 11.9% | ||
| Jan 12 | TPG Inc. | Finance | 29.5 | 33 | JPM | GS | MS | 44% | 15.3% | ||
| Jan 7 | CinCor Pharma I | Health-Care | 16 | 12 | MS | JEFF | EVCR | 23.2% | 0% | ||
| Jan 7 | Vigil Neuroscie | Health-Care | 14 | 7 | MS | JEFF | Stifel | 31.6% | -9.6% | ||
*
Lead manager or one of top three managers in an underwriting team.